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Introduction

Results

Conclusions

In the United States, more than 18
million people suffer from depression
making it the number 1 cause of
disability worldwide. Since Prozac was
introduced 30 years ago there have only
been new variations of existing selective
serotonin reuptake inhibitors (SSRI) and
serotonin norepinephrine reuptake
inhibitors (SNRI). Although this is the
case, over 50% of individuals do not
respond to existing antidepressants.
Researchers have been studying the use
of psychedelic therapy (psilocybin, LSD,
etc.) in the treatment of chronic
depression.

● The data showed an improvement in
depressive symptoms in patients
who participated in the clinical
trials.
● The effects of psychedelic therapy
compared to prescribed
antidepressants showed similar or
better improvement in feelings of
depression.
● The Trial of Psilocybin versus
Escitalopram for Depression
displayed there was no significant
difference between the two and
resulted in no serious adverse
effects.
● Some common adverse effects seen
in patients using psilocybin therapy
include headache, nausea, and
fatigue.
● The article Effects of
Psilocybin-Assisted Therapy on
Major Depressive Disorder (MDD)
discovered psilocybin was effective
in managing MDD, alongside
psychological support.
● LSD use revealed a reduce in
anxiety, feelings of happiness and
trust, and no serious adverse effects.

● The conclusion of our research
shows the use of psychedelic therapy
in treatment of depression has a
significant decrease in depressive
symptoms in patients struggling with
chronic depression.
● Although some studies have shown
psychedelics are effective in treating
chronic depression, more trials are
needed to be done before it can be
used for treatment throughout the
nation.

PICO
In (P) patients with chronic depression,
(I) does the use of psychedelic therapy,
(C) compared to patients on
antidepressant, (O) improve mood and
signs of depression?
Methods
We examined research articles in
CINAHL and PsycINFO, focusing on the
keywords:
●
●
●
●
●

“Psychedelic therapy”
“Depression”
“Hallucinogens''
“Psilocybin”
“LSD”

(Carhart-Harris et al., 2021)

Considerations
There are many factors that impact the
outcome of psychedelic therapy. For
example, a study conducted in Maryland
implemented music, sunglasses, and
headphones during psilocybin dosing
sessions (Davis et al., 2021). Unlike
prescribed antidepressants such as SSRIs
where the effect of the therapy is the
pharmacological action of the drug, the
therapeutic effect of psychedelic therapy
is affected by:
●
●
●
●
●
●
●
●

Mental state
Subjective experience
Quality of psychosocial support
Context of consumption during dosing
Integration post consumption
Memories
Perceptions
Supportive environment

(Jairaj, Rucker, et al, 2022)
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